Latest news from Cochrane

• Cochrane's statement to the 74th World Health Assembly (1 June 2021)
• Cochrane shows support for WHO-ICMRA statement on transparency and data integrity (7 May 2021)
• Cochrane signs letter asking medicines regulators in Europe to address unpublished clinical trials (10 May 2021)
• New independent study finds Cochrane’s transparency over reporting financial conflicts of interest is leading the way 20 May 2020
• Cochrane Centres call for transparency of COVID-19 clinical studies 20 May 2020
• Cochrane's statement to the 73rd World Health Assembly 18 May 2020
• Cochrane’s statement in support of EMA’s clinical study report transparency policy 13 January 2020
• BMJ blog: Karla Soares-Weiser: Cochrane announces a new, more rigorous “conflict of interest” policy 3 December 2019
• Cochrane supports AllTrials report on UK clinical trial transparency used as a basis for parliament evidence session 8 November 2019
• Cochrane advocates for clinical trial transparency at EU Parliament event 25 October 2019
• 2019 Cochrane-REWARD Prize winners announced 18 October 2019
• Cochrane CSR Working Group’s open letter in response to the FDA’s public comment request on the Clinical Data Summary Report Pilot 22 August 2019
• Cochrane supports European regulators as they urge clinical trial sponsors to share their results 10 July 2019

Resources and activities from Cochrane Groups

• Watch the video: Cochrane Sweden host webinar on clinical trial transparency
• US FDA begins enforcement of clinical trial transparency regulation
• Cochrane Belgium partners on clinical trial transparency report
• Cochrane Austria launches joint trial transparency report
• Cochrane Sweden highlights under-reporting of Swedish clinical trials
• Cochrane Germany explains why a lack of trial transparency harms health